US stocks fell on Wednesday, with the Dow breaking a four-day string of record closing highs, following the World Bank's reduction of its global growth forecast.
The S&P 500's drop of 0.4% was its biggest daily percentage loss since May 20. The benchmark index fell for the second day in a row, after four straight record closing highs.
The selloff was broad. Every S&P 500 sector index except energy declined for the day.
Low volume and low volatility have marked recent sessions, leaving indexes to trade in a narrow range.
The World Bank's lower growth forecast provided investors with a reason to unload some stocks. Late Tuesday, the World Bank cut its global economic growth forecast for 2014 to 2.8% from 3.2% because of a harsh US winter and the impact of the Ukraine crisis.
"It's pretty quiet. The only news investors are keying in on is the forecast of slightly lower global growth," said Dan Veru, chief investment officer of Palisade Capital Management LLC in Fort Lee, New Jersey, which oversees $4 billion.
"I think it's an excuse for some investors to take some money off the table."
The biggest drag on the S&P 500 was Bank of America Corp, down 2.1% at $15.59. The bank has reached an impasse in negotiating a multibillion-dollar settlement with the US Department of Justice related to the bank's mortgage investments, according to The New York Times.
Investors turned cautious after the surprising primary election defeat of Eric Cantor, the No. 2 Republican in the House of Representatives, by an upstart candidate from the Tea Party movement.
The Dow Jones industrial average fell 102.04 points or 0.60%, to 16,843.88. The S&P 500 slid 6.90 points or 0.35%, to 1,943.89. The Nasdaq Composite dropped 6.07 points or 0.14%, to 4,331.93.
Even as the Dow and the S&P 500 retreated from recent gains, the PHLX semiconductor index kept up its rally. The SOX rose 0.5%, extending its winning streak to 15 days, its longest stretch of gains since the index was created about 20 years ago.
Leading the SOX higher, Micron Technology Inc rose 5% to $30.99 a day after Credit Suisse raised its price target on the memory chipmaker's stock to $50 from $30.
The CBOE Volatility Index rose 5.6% to 11.60 but remained well below its historical average of 20. In a sign of the market's low volatility, the 14-day Average True Range on the S&P 500 fell to 9.71, the lowest since February 2013.
Orexigen Therapeutics Inc shares sank 14.7% to $5.81 after the US Food and Drug Administration delayed a decision on the marketing application for its obesity drug by three months.
Volume was once again below average. With just 5.2 billion shares changing hands on US exchanges, Wednesday's volume was below the 5.76 billion average for the last month, according to data from BATS Global Markets.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)